Palczuk Linda has filed 27 insider transactions across 1 company since January 2023.
Most recent transaction: a disposition of 60000 shares of AVADEL PHARMACEUTICALS PLC ($AVDL) on February 12, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.06% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Ordinary Shares | 78905 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.08% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.02% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.03% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Sept. 15, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 95,141,000 | 50.00% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Ordinary Shares | 11000 | $0.00 | 78,900.0000 | 95,141,000 | 16.20% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 95,141,000 | 9999.99% | 0.01% |
| Jan. 24, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 95,141,000 | 50.00% | 0.03% |
| Jan. 21, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | P | Ordinary Shares | 5000 | $7.93 | 67,900.0000 | 95,141,000 | 7.95% | 0.01% |
| Dec. 24, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Ordinary Shares | 3500 | $0.00 | 62,900.0000 | 96,300,000 | 5.27% | 0.00% |
| Dec. 17, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 96,300,000 | 9999.99% | 0.03% |
| Dec. 6, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | P | Ordinary Shares | 3000 | $10.19 | 66,400.0000 | 96,300,000 | 4.73% | 0.00% |
| Sept. 15, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 80,174,000 | 50.00% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 80,174,000 | 9999.99% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Ordinary Shares | 11000 | $0.00 | 63,400.0000 | 80,174,000 | 20.99% | 0.01% |
| Sept. 1, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 60,094,000 | 50.00% | 0.05% |
| Aug. 1, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 60,094,000 | 9999.99% | 0.05% |
| May 9, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | P | ADSs | 2500 | $14.76 | 52,400.0000 | 60,094,000 | 5.01% | 0.00% |
| Jan. 20, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 60000 | $0.00 | 186,000.0000 | 60,094,000 | 24.39% | 0.10% |
| Jan. 20, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 42000 | $0.00 | 186,000.0000 | 60,094,000 | 18.42% | 0.07% |
| Jan. 20, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 42000 | $0.00 | 186,000.0000 | 60,094,000 | 18.42% | 0.07% |
| Jan. 20, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Palczuk Linda | Director | G | Stock Option (Right to Buy) | 42000 | $0.00 | 186,000.0000 | 60,094,000 | 18.42% | 0.07% |